Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Clonal evolution in myelodysplastic syndromes

P. da Silva-Coelho, LI. Kroeze, K. Yoshida, TN. Koorenhof-Scheele, R. Knops, LT. van de Locht, AO. de Graaf, M. Massop, S. Sandmann, M. Dugas, MJ. Stevens-Kroef, J. Cermak, Y. Shiraishi, K. Chiba, H. Tanaka, S. Miyano, T. de Witte, NMA....

. 2017 ; 8 (-) : 15099. [pub] 20170421

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19001270

Cancer development is a dynamic process during which the successive accumulation of mutations results in cells with increasingly malignant characteristics. Here, we show the clonal evolution pattern in myelodysplastic syndrome (MDS) patients receiving supportive care, with or without lenalidomide (follow-up 2.5-11 years). Whole-exome and targeted deep sequencing at multiple time points during the disease course reveals that both linear and branched evolutionary patterns occur with and without disease-modifying treatment. The application of disease-modifying therapy may create an evolutionary bottleneck after which more complex MDS, but also unrelated clones of haematopoietic cells, may emerge. In addition, subclones that acquired an additional mutation associated with treatment resistance (TP53) or disease progression (NRAS, KRAS) may be detected months before clinical changes become apparent. Monitoring the genetic landscape during the disease may help to guide treatment decisions.

Department of Hematology Radboud University Medical Center Geert Grooteplein Zuid 8 6525 GA Nijmegen The Netherlands

Department of Hematology Radboud University Medical Center Geert Grooteplein Zuid 8 6525 GA Nijmegen The Netherlands Department of Hematology University Medical Centre Groningen PO Box 30001 9700 RB Groningen The Netherlands

Department of Human Genetics Radboud University Medical Center Geert Grooteplein Zuid 8 6525 GA Nijmegen The Netherlands

Department of Pathology and Tumor Biology Graduate School of Medicine Kyoto University Yoshida Konoe cho Sakyo ku Kyoto shi Kyoto 606 8501 Japan

Department of Tumor Immunology Radboud University Medical Center Radboud Institute for Molecular Life Sciences Geert Grooteplein Zuid 8 6525 GA Nijmegen The Netherlands

Human Genome Center Institute of Medical Science The University of Tokyo 4 6 1 Shirokanedai Minato ku Tokyo 108 8639 Japan

Institute of Hematology and Blood Transfusion U Nemocnice 1 128 20 Prague 2 Czech Republic

Institute of Medical Informatics University of Münster Albert Schweitzer Campus 1 48149 Münster Germany

Laboratory of Hematology Radboud University Medical Center Geert Grooteplein Zuid 8 6525 GA Nijmegen The Netherlands

Laboratory of Hematology Radboud University Medical Center Geert Grooteplein Zuid 8 6525 GA Nijmegen The Netherlands Department of Haematology Centro Hospitalar de São João and Faculdade de Medicina da Universidade do Porto Alameda Professor Hernâni Monteiro Porto 4200 319 Portugal

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19001270
003      
CZ-PrNML
005      
20200121092740.0
007      
ta
008      
190107s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/ncomms15099 $2 doi
035    __
$a (PubMed)28429724
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a da Silva-Coelho, Pedro $u Laboratory of Hematology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands. Department of Haematology, Centro Hospitalar de São João and Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro, Porto 4200-319, Portugal.
245    10
$a Clonal evolution in myelodysplastic syndromes / $c P. da Silva-Coelho, LI. Kroeze, K. Yoshida, TN. Koorenhof-Scheele, R. Knops, LT. van de Locht, AO. de Graaf, M. Massop, S. Sandmann, M. Dugas, MJ. Stevens-Kroef, J. Cermak, Y. Shiraishi, K. Chiba, H. Tanaka, S. Miyano, T. de Witte, NMA. Blijlevens, P. Muus, G. Huls, BA. van der Reijden, S. Ogawa, JH. Jansen,
520    9_
$a Cancer development is a dynamic process during which the successive accumulation of mutations results in cells with increasingly malignant characteristics. Here, we show the clonal evolution pattern in myelodysplastic syndrome (MDS) patients receiving supportive care, with or without lenalidomide (follow-up 2.5-11 years). Whole-exome and targeted deep sequencing at multiple time points during the disease course reveals that both linear and branched evolutionary patterns occur with and without disease-modifying treatment. The application of disease-modifying therapy may create an evolutionary bottleneck after which more complex MDS, but also unrelated clones of haematopoietic cells, may emerge. In addition, subclones that acquired an additional mutation associated with treatment resistance (TP53) or disease progression (NRAS, KRAS) may be detected months before clinical changes become apparent. Monitoring the genetic landscape during the disease may help to guide treatment decisions.
650    _2
$a senioři $7 D000368
650    _2
$a inhibitory angiogeneze $x terapeutické užití $7 D020533
650    _2
$a nádorové biomarkery $x genetika $x metabolismus $7 D014408
650    _2
$a buňky kostní dřeně $x účinky léků $x metabolismus $x patologie $7 D001854
650    _2
$a klonální evoluce $x účinky léků $7 D060965
650    _2
$a management nemoci $7 D019468
650    _2
$a progrese nemoci $7 D018450
650    _2
$a chemorezistence $x genetika $7 D019008
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a GTP-fosfohydrolasy $x genetika $x metabolismus $7 D020558
650    12
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a lidé $7 D006801
650    _2
$a lenalidomid $7 D000077269
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové proteiny $x genetika $x metabolismus $7 D008565
650    _2
$a lidé středního věku $7 D008875
650    _2
$a monitorování fyziologických funkcí $7 D008991
650    _2
$a mutace $7 D009154
650    _2
$a myelodysplastické syndromy $x farmakoterapie $x genetika $x metabolismus $x patologie $7 D009190
650    _2
$a protoonkogenní proteiny p21(ras) $x genetika $x metabolismus $7 D016283
650    _2
$a thalidomid $x analogy a deriváty $x terapeutické užití $7 D013792
650    _2
$a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
650    _2
$a sekvenování exomu $7 D000073359
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kroeze, Leonie I $u Laboratory of Hematology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.
700    1_
$a Yoshida, Kenichi $u Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto-shi, Kyoto 606-8501, Japan.
700    1_
$a Koorenhof-Scheele, Theresia N $u Laboratory of Hematology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.
700    1_
$a Knops, Ruth $u Laboratory of Hematology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.
700    1_
$a van de Locht, Louis T $u Laboratory of Hematology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.
700    1_
$a de Graaf, Aniek O $u Laboratory of Hematology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.
700    1_
$a Massop, Marion $u Laboratory of Hematology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.
700    1_
$a Sandmann, Sarah $u Institute of Medical Informatics, University of Münster, Albert-Schweitzer-Campus 1, 48149 Münster, Germany.
700    1_
$a Dugas, Martin $u Institute of Medical Informatics, University of Münster, Albert-Schweitzer-Campus 1, 48149 Münster, Germany.
700    1_
$a Stevens-Kroef, Marian J $u Department of Human Genetics, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.
700    1_
$a Cermak, Jaroslav $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic.
700    1_
$a Shiraishi, Yuichi $u Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639 Japan.
700    1_
$a Chiba, Kenichi $u Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639 Japan.
700    1_
$a Tanaka, Hiroko $u Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639 Japan.
700    1_
$a Miyano, Satoru $u Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639 Japan.
700    1_
$a de Witte, Theo $u Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.
700    1_
$a Blijlevens, Nicole M A $u Department of Hematology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.
700    1_
$a Muus, Petra $u Department of Hematology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.
700    1_
$a Huls, Gerwin $u Department of Hematology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands. Department of Hematology, University Medical Centre Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands.
700    1_
$a van der Reijden, Bert A $u Laboratory of Hematology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.
700    1_
$a Ogawa, Seishi $u Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto-shi, Kyoto 606-8501, Japan.
700    1_
$a Jansen, Joop H $u Laboratory of Hematology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.
773    0_
$w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 8, č. - (2017), s. 15099
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28429724 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20200121093117 $b ABA008
999    __
$a ok $b bmc $g 1365158 $s 1039393
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 8 $c - $d 15099 $e 20170421 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
LZP    __
$a Pubmed-20190107

Najít záznam

Citační ukazatele

Možnosti archivace